Medically reviewed by Erika Prouty, PharmD Key Takeaways There are two types of complement 3 glomerulopathy: dense deposit ...
Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...
Apellis Pharmaceuticals (NASDAQ:APLS) used its presentation at the 44th Annual JPMorgan Healthcare Conference to outline its ...
The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
Advancing investigational pre-clinical research of APL-9099 3, a potential one-time neonatal Fc receptor (FcRn) treatment ...
Say the words “Olandria Carthen” or “Hudson Williams” on the internet, and two equally rabid fandoms will be summoned, ready ...
He’s been a unionist and a political fixer. Now the ex-Labor powerbroker opens up about his biggest job yet – running the ...
US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...
NEW YORK, NY, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Blending Medical Expertise, Faith, and Personal ...
The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...
These 10 humble spots offer smoky delights and fall-off-the-bone goodness that will have you coming back for seconds! Buster’s brings authentic Texas-style barbecue to the heart of Oregon, and boy, ...
Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...